Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Soy foods may lower colon cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Mouse models help target specific genes in lymphatic cells for research.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

We need to understand more about regeneration to improve human tissue healing.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Non-coding RNAs are crucial for skin development and health.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

New drug delivery systems improve treatment effectiveness and patient experience.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Injectable exosomal micro RNAs may help regrow hair.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Single-cell encapsulation shows promise for medical use but faces production challenges.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

Injection therapies show promise as effective treatments for hair loss.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Injecting specific oligonucleotides can change hair growth and structure by altering a gene.